Open AccessSuccessful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
Author(s) -
Kapuczinski Abeline,
Cotils Michel,
Gombeir Yannick
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4180
Subject(s) - rituximab , medicine , interstitial pneumonia , pneumonia , salvage therapy , intensive care medicine , covid-19 , usual interstitial pneumonia , lung , immunology , pathology , disease , lymphoma , infectious disease (medical specialty) , chemotherapy
Interstitial pneumonia with autoimmune features is a complex and heterogeneous research classification without clear management and should be discussed on a case‐by‐case basis in a pluridisciplinary way. Rituximab could be used for severe lung involvement. The coronavirus crisis can hide other pathologies in such a way that a diagnosis can be overlooked.